NYSCF and CMTA Announce Largest-Ever Research Resource for Neuropathy Disorders
Stem cell lines resulting from a pathbreaking collaboration beginning in 2014 between The NYSCF Research Institute and the Charcot-Marie-Tooth Association (CMTA) are now available for use by other researchers in the largest and first ever initiative of its kind.
The CMTA provided and coordinated nineteen patients with a number of Charcot-Marie-Tooth diseases who provided fibroblasts, or skin cells, for research. NYSCF Research Institute scientists took these patient samples and turned them into induced pluripotent stem cell lines using its automated technology, the NYSCF Global Stem Cell Array.
These stem cell lines represent the largest collection of lines for a variety of neuropathy disorders of known genetic causation.